The Canadian cannabis space is one of the hottest growing sectors. Are you interested in cannabis investment? Here’s a look at Canadian cannabis stocks for investors to consider.
By Jocelyn Aspa and Bryan Mc Govern
Canadian cannabis stocks have been on investors’ lips the last year. When it comes to cannabis investment, there are so many large and small companies on different exchanges, market watchers are left wondering what Canadian cannabis stocks are out there to choose from? Plus, what are the legal implications and what are the risks in this sector? The Canadian cannabis sector is taking huge steps in establishing guidelines for their product and finding international opportunities in the medical landscape, while the recreational market will officially be legalized in 2018.
Down in the US, a number of states are in various phases of legalization for both medical and recreational marijuana use. In Canada the situation is a bit clearer which is good for cannabis investment. However, new players are appearing causing disruption for investors looking to enter the cannabis investment space. That said, there are good opportunities in Canadian cannabis stocks for those willing to do their research.
Business in cannabis has expanded into massive levels of investment thanks to opportunities in various stock listings. In Canada, cannabis companies can seek public investment through stock listings on the Toronto Stock Exchange (TSX), its smaller sibling market TSX Venture (TSXV) and the Canadian Securities Exchange (CSE).
For those interested in cannabis investment, here’s a look at a variety of publicly traded Canadian cannabis stocks. The list includes cannabis and hemp focused stocks divided by the respective Canadian exchange.
The TSX has seen leaders of the cannabis industry join its listing and offer investors a new venue into cannabis ventures. These include massive license producers (LPs) expanding their product and brands overseas.
Also licensed under the ACMPR, much like other companies on the Canadian cannabis stocks, Aphria is located in Leamington, Ontario. The company self-describes itself as “truly powered by sunlight”, which they state allows for natural growing conditions to produce safe medical cannabis products.
Aphria made its strategic entrance to the US cannabis market through Liberty Health Sciences (CSE:LHS; OTCBB:LHSIF), which seeks and partners with cannabis companies in the US. Its first market is in Florida. Despite its interest in the American market, the company was forced to dump its assets south of the border due to regulations issues with the TMX Group. Aphria sold its cannabis investment in an Arizona producer to Liberty Health and plans to let go of its own stake in Liberty Health.
Aurora Cannabis (TSX:ACB)
Next on our stock list for cannabis investment is Aurora Cannabis. This company is currently fast at work on the development of their Aurora Sky facility, an 800,000 square foot hybrid greenhouse, which obtained its cultivation license from Health Canada, the country’s regulator.
As part of their most recent quarterly update to shareholders the company revealed it had reached $11.7 million in revenue for the second quarter of their fiscal 2018 year. The company also shared some details on one of their most recent partnerships, an investment deal with Liquor Stores N.A. meant to plan for the creation of cannabis retail outlets.
The company explained its new investee will convert existing retail locations into specific cannabis outlets while also looking for new spaces to develop.
Now the company continues its path of cannabis investments and acquisitions by announcing a deal to purchase MedReleaf (TSX:LEAF). The deal is worth over C$3 billion to buy all the issued and outstanding common shares of MedReleaf.
CannTrust Holdings (TSX:TRST)
CannTrust became the sixth LP to join the TSX when its shares officially launched in the premier Canadian exchange on March 5. The company skipped the TSX Venture exchange entirely and upgraded from the Canadian Securities Exchange (CSE).
“Graduating to the TSX reflects the amazing progress we have made since listing on the CSE in August last year and represents yet another important milestone for CannTrust as we continue our successful journey as one of Canada’s leading cannabis companies” Eric Paul, CEO of CannTrust said.
This year the Canadian cannabis stock managed to complete a $15,000,000 mortgage financing deal for its greenhouse facility in Niagara.
Canopy Growth (TSX:WEED)
Most investors in the cannabis investment space will know of Canopy Growth, the largest Canadian cannabis stock, having been the first cannabis organization to surpass the $1 billion market cap.
Canopy holds producers Tweed and Bedrocan under its umbrella. Tweed’s production facility is located in the old Hershey factory in Smith Falls, Ontario, while its breeding facility was completed in September 2016. The company believes the state-of-the-art facility is the first of its kind and will form the foundation of new Canadian-bred genetics.
Canopy regularly announces new deals and partnerships with international emerging markets. Late in 2017, the company announced a deal that sent a signal to the entire industry. Constellation Brands (NYSE:STZ), a massive alcohol producer in the US, invested in 9.9 percent equity of Canopy, which signaled the increased credibility of the cannabis business to the overall market.
Following in the steps of Cronos Group (NASDAQ:CRON), Canopy announced its intentions to list on the New York Stock Exchange. The company is trading in the US under the ticker symbol “CGC”, giving Americans interested in cannabis investment another stock to choose from.
Cronos Group (TSX:CRON)
Next on our stock list for cannabis investment is Cronos, a Canadian licensed producer with assets in international markets such as Australia and Israel. This year the company became the first Canadian LP to list its common shares on the Nasdaq Global Markets. The company does not own any assets in the US but has indicated it wishes to enter the market once all legal issues are cleared for the drug.
Since the start of the year, the company has been raising money with a couple of different bought deals, worth C$46 million and C$100 million separately. The company upgraded its Canadian shares to the TSX on May 22.
As part of its first-quarter result update for 2018, the company reported C$2.9 million in sales representing a C$2.4 million increase from the same quarter during the previous year.
MedReleaf is one of the Canadian cannabis stocks whose company is working to advance the knowledge available on the therapeutic benefits of cannabis for patient care. At the Canaccord cannabis investor day conference, they revealed throughout 2018 their four primary areas of focus included the Canadian medical cannabis market and opportunities over in the international market.
The company was rumored to begin a process of making players know the company was available for the taking. The rumors were then confirmed once an acquisition deal with Aurora Cannabis was announced.
Publicly launched this year, this company counts with the backing from major Canadian LP Aurora Cannabis, even appointing Cam Battley, chief corporate officer with Aurora, into TGOD’s board of directors.
The company was able to close its initial public offering with gross proceeds worth $132,263,225 under the IPO thanks in part to issue an additional 36,236,500 units of the company, and including the over-allotment units to financial institutions.
“The further investments by Aurora Cannabis… in both the IPO and the Over-Allotment Option bring Aurora’s total investment in the Company to $78,145,562 and further validate TGOD’s business plan and value,” Robert Anderson, TGOD’s Co-Chairman and CEO said in a statement.
Previously known as the Canadian Venture Exchange, the TSX Venture Exchange is the sibling listing from the larger Toronto Stock Exchange. This listing offers a variety of Canadian cannabis stocks ranging from growers to biotech companies looking for cannabinoid (CBD) therapies.
ABcann Global (TSXV:ABCN)
First on our TSXV stock list for cannabis investment is ABcann became public this year with a complete TSXV listing. This licensed producer is set to expand with additions to their staff and new 100,000-square-foot facility set to add to their current 625 kilograms per year production.
The Canadian cannabis stock evaluates its product under a climate-controlled chamber, which allows it to put out a uniform product and be safer when it comes to new Health Canada randomized inspections on cannabis from its producers. In July, ABcann announced its listing on the OTCQB Marketplace and Frankfurt Stock Exchange. Prior to that, it–together with Cannabis Wheaton–announced the signing of an agreement for the first tranche of a $15 million placement.
Auxly Cannabis Group (TSXV:XLY)
Previously known as Cannabis Wheaton Income, this cannabis investment company operates employing the streaming business plan made popular in the mining sector. Therefore Auxly scans the sector and provides funding support for other companies in the investment space. In return, the company gets minority equity interests and a percentage of the cultivation.
President Hugo Alves told INN the cannabis investment company overcame an unsuccessful offering deal with two financial banking institutions to continue their financing business with other cannabis businesses in Canada.
BLOCKStrain Technology (TSXV:DNAX)
BLOCKStrain is a software company working on a blockchain-based platform for supply chains management in the cannabis industry. The company has signed deals with cannabis producers WeedMD (TSXV:WMD) and Abattis Bioceuticals (CSE:ATT) for the use of its platform.
Delta 9 Cannabis (TSXV:NINE)
Next on our stock list for cannabis investment is Delta 9. The company is a cannabis producer located in Manitoba and currently in the running for one of the four master licenses set to be awarded to companies for the involvement of the upcoming cannabis market in that province. They partnered with Canopy Growth (TSX:WEED) for their business development under their CraftGrow program.
“We are already working closely on a project to jointly serve the growing market in Manitoba; this project brings Delta 9’s craft grown cannabis products to a wider national audience through Canopy Growth’s well-established CraftGrow network,” Delta 9 CEO John Arbuthnot said.
Like most other Canadian cannabis investment stocks, Emblem is a licensed producer in Canada, currently using the latest in indoor grow science. The company’s new facility located in Ontario was designed with a purpose to cultivate and cure cannabis for medicinal use. Emblem gave the go-ahead in December 2016 from Health Canada to begin production of cannabis oil.
In November of 2017, the company announced has been granted a license to sell cannabis oils expanding their business options in the market.
Emerald Health Botanicals (TSXV:EMH)
Emerald Health Botanicals, previously Emerald Health therapeutics, is a licensed medical marijuana producer under MMPR. As a federal research grant recipient, the Canadian cannabis stock conducts research and development into the characterization of cannabis strains and cultivation technologies. It also collaborates with academic and medical research to help gain further understanding of the effect of cannabis on humans.
For those wanting to gain exposure to cannabis investment without directly investing in an LP, technology is a good option. FluroTech is a technology company working on a cost-effective testing platform for the cannabis industry at large. The company’s proprietary CompleTest employing fluorescence spectroscopy technology to measure specific contents of the product.
The company began trading publicly on the TSXV on June 12 after obtaining approval from the exchange. “It is expected the company will launch its marketing program to licensed producers with direct sales of the portable and desktop testing devices for heavy metal and potency tests this summer,” FluroTech said.
Harvest One Cannabis (TSXV:HVT)
Harvest One conducts its business thanks to three different units, United Greeneries provides the horticultural arm while Satipharm AG serves the medical arm. Those two are under the Harvest One umbrella. Each business is strategically located with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation license. The company announced on May 9 it had completed its first international shipment, with product heading to Australia.
The Hydropothecary Corporation (TSXV:THCX)
Also a licensed producer, this cannabis investment option sells their product through their website and grows it under a glass roof greenhouse, which makes it so their crops receive direct sunlight.
Hydropothecary went public in March following a couple of false starts, according to the Financial Post, the company joined the TSXV due to the potential for legalization on the recreational market.
This year the company announced the appointment of Dr. Terry Lake, former B.C. Minister of Health, as their new vice-president of corporate social responsibility.
ICC Labs (TSXV:ICC)
This licensed integrated Canadian cannabis stock operates out of Uruguay, a leader in the legal cannabis investment space and a model many other countries have looked for a similar strategy. ICC is also investing in cannabis research to improve understanding of its physical uses and medical benefits.
The Canadian cannabis stock obtained two licenses to enter the medical cannabis market in Colombia, adding to its reach in the Latin American cannabis investment market.
INDIVA is a relatively new player in the cannabis investment space, their focus is on the supply of medical cannabis. Through an acquisition, this company holds a licensed producer with an indoor cannabis facility in Ontario.
The Canadian cannabis stock signed an exclusive agreement with Medropharm GmbH and Greenfields Health Care for the exclusive supply of cannabis strains in Canada. “Through our relationship with Medropharm and Greenfields we not only gain access to certain in-demand high-CBD cannabis strains we will also benefit from their extensive research and innovation,” INDIVA CEO Niel Marotta said.
Invictus MD (TSXV:IMH)
Invictus hosts a platform for cannabis, located in Vancouver, the company wants to capitalize on the upcoming cannabis legalization process the federal government is set to take.
Invictus announced in April 2017 an agreement with Canopy Growth to allow the sale of the product from AB Labs, which was partly acquired by Invictus last year, on the Tweed Main Street’s online store. On June 23, Invictus announced it had been included on the Horizons Marijuana Life Sciences Index ETF.
Kalytera Therapeutics (TSXV:KALY)
Next on our stock list for cannabis investment is Kaltera. This clinical-stage pharmaceutical is working on developing the latest in therapies available through the use of cannabis. Kalytera is developing a new class of proprietary CBD therapeutics.
At the end of May, Kalytera announced its first quarter 2017 financial results, highlighting that the Canadian cannabis stock was spending $404,000 on research and development. In September the company received approval from the Institutional Review Board at one of two clinical sites in Israel to commence a Phase 2 study to evaluate cannabidiol (CBD) for the prevention of GvHD.
Khiron Life Sciences (TSXV:KHRN)
Khiron is a cannabis producer in Colombia raising capital in Canada through the TSX Venture Exchange. CEO Alvaro Torres told INN he wants to expand the strategy currently employed in Colombia for other Latin American markets such as Mexico.
Torres said as the Canadian market continues to grow with oversaturation investors will look to new opportunities like Colombia in the case of Khiron, with a patient population higher than the one in Canada.
Namaste Technologies (TSXV:N)
Namaste is a company offering consumers an entirely new platform where they can access and purchase vaporizer products from official manufacturers, and if allowed by the country medical cannabis. In Canada, the company has signed deals with licensed producers (LPs) to offer their products in the NamasteMD app. Through the mobile application, patients can obtain a prescription for medical marijuana.
Sean Dollinger, president, and CEO of Namaste told INN the company plans to launch a smartwatch app that will be able to collect data from the users after consuming cannabis products.
National Access Cannabis (TSXV:NAC)
This Canadian cannabis stock earned one of the coveted retail licenses for the province of Manitoba, which helped boost its share price so far in 2018. National Access Cannabis announced it was planning to strengthen its relationship with a few very different cannabis companies: CannaRoyalty, Cannabis Wheaton Income, and Tilray.
The license was a win for the company’s decision to partner with the Nisichawayasihk Cree Nation of Manitoba to establish a retail recreational cannabis store in Thompson, Manitoba.
Naturally Splendid (TSXV:NSP)
Naturally Splendid has a slightly different focus than some of the other companies here on the Canadian cannabis stocks list. Rather than being involved in the medical marijuana space, the company offers investors exposure to the hemp-based healthy foods, omega, and cannabinoid markets.
The company announced it started shipping their NATERA(R) brand of products to an Australian distributor, opening the doors to a new cannabis market.
Newstrike Resources (TSXV:HIP)
Through its subsidiary, Up Cannabis, Newstrike plans on developing various cannabis brands which would address medical client needs and as full legalization rolls into the country, recreational consumers as well. This licensed producer inked a deal with the Canadian band The Tragically Hip to contribute creatively to the company’s efforts.
Shareholders of the Canadian cannabis stock voted in favor of being acquired by CanniMed Therapeutics (TSX:CMED) in January 2018, only for CanniMed to then cut a deal with Aurora Cannabis (TSX:ACB) and drop the potential acquisition of Newstrike.
OrganiGram Holdings (TSXV:OGI)
As its name suggests, OrganiGram specializes in producing organically grown medical marijuana. The company is licensed under the ACMPR and has a production facility located in Moncton, New Brunswick.
The Canadian cannabis stock has been actively involved with the business plan for the province of New Brunswick, it’s home location. The company also announced a support agreement with le Collège Communautaire du Nouveau-Brunswick (CCNB) and the New Brunswick Department of Post-Secondary Education, Training and Labour “to support the delivery of the first commercial cannabis cultivation technician program in Canada.”
Radient Technologies (TSXV:RTI)
Radient is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis. The partnership was unveiled this year and since then the two companies have provided an update on the status of their collaboration.
A press release from Aurora revealed the intention behind this partnership was to achieve a superior standardized cannabinoid extract.
“The potential to substantially increase our extracts production capacity while maintaining terpene profiles would further differentiate our Company, and we are excited to be exploring this opportunity further in the coming weeks,” said Aurora’s CEO Terry Booth in the same release.
Scythian Biosciences (TSXV:SCYB)
Scythian is a research and development company with a patent application for the use of cannabinoids for the treatment of brain trauma injuries. This Canadian cannabis stock received a hefty investment from Aphria (TSX: APH), which acted as a leader of a private placement deal.
Tetra Bio-Pharma (TSXV:TBP)
This Canadian cannabis stock operates in the drug discovery and development aspect of cannabis, more specifically cannabinoid-based drugs. Most recently the company obtained approval from Health Canadafor their phase 2 cannabis oil trial.
“We currently have a strong pipeline of five cannabinoid-based products, all launched last year and using different delivery systems, in various stages towards Health Canada and FDA approval,” Bernard Fortier, CEO of Tetra Bio-Pharma’s said.
The Supreme Cannabis Company (TSXV:FIRE)
Supreme is next on our Canadian cannabis stocks list. Located in Kincardine, Ontario, the company’s federally approved medical marijuana company, 7ACRES, cultivates medical marijuana on a greenhouse cost base. Along with 24 other companies, Supreme received its federal license in March of 2016.
In October the company announced its partner 7ACRES obtained Health Canada approvals in order to start cultivation at the recently completed 30,000 square feet flowering rooms at their hybrid facility.
Another officially licensed producer in Canada, WeedMD is focused on the growth of medical cannabis and sells its product directly to customers through their website. In May the company announced they received a sale license, which expands their business to include the sale of 1,200kg dried medicinal product per year.
Earlier this year the company joined the TSXV. The Canadian cannabis stock is looking to perform an expansion with a 220,000 square feet facility as it prepares for the recreational market to open in Canada. On June 28, it was announced that the company had entered a strategic partnership with Aurora Cannabis. Prior to that, WeedMD announced that it had secured a license from Health Canada to produce cannabis oils.
The Canadian Securities Exchange (CSE) offers investors with a variety of cannabis-related companies seeking to increase their business activities. The CSE offers Canadian companies an option to seek business possibilities in the US, as long as it manages to disclose all its risks properly to shareholders. Let’s take a look at some of the Canadian cannabis stocks listed there.
Abattis Bioceuticals (CSE:ATT)
Abattis Bioceuticals is a vertically integrated biotechnology company focused on natural health products, including cannabis. The company develops natural health products and conducts research and development for the pharmaceutical, nutraceutical, bioceutical and cosmetic markets.
This year the Canadian cannabis stock has expanded their work in novel cannabis products with a partnership to develop a hemp-infused, cannabinoid-rich, THC-free craft beer alongside Vancouver-based craft brewery Faculty Brewing.
Alliance Growers (CSE:ACG)
In its attempt to scale up on the cannabis market from a regional, national and international scope, ACG has moved to develop a Cannabis Botany Centre with Botanical Research In Motion International to jointly develop and operate multiple cannabis-focused Botany centers in Canada.
The Canadian cannabis stock provided an update to shareholders on their acquisition of Biocannatech, a late-stage licensed producer applicant under Health Canada’s access to cannabis for medical purposes regulations (ACMPR) in Quebec.
Next on our stock list for cannabis investment is Beleave, a biotech company with a focus on becoming a licensed producer of medical-grade cannabis under the ACMPR. Its wholly-owned subsidiary, First Access, applied for a pre-license inspection in March 2017.
On January 31 the company announced it received a notification from Health Canada about its pre-sale inspection, which is now scheduled for February 8. If approved the Canadian cannabis stock will obtain a cannabis sales license.
Cannabix Technologies (CSE:BLO)
On the technology side of things, Cannabix Technologies is developing a breathalyzer that detects THC for use by law enforcement. The company announced its inclusion in the CSE25 Index in November 2017.
Most recently the company provided an update to shareholders of the development for their marijuana breathalyzer. “With completion of the modular Beta 3.0 prototype, Cannabix has achieved several key developmental milestones allowing this technology to be directly tested against the accepted laboratory standard of mass spectrometry,” Chief Scientific Officer, Dr. Raj Attariwala said.
Canntab Therapeutics (CSE:PILL)
Canntab is offering investors a different type of play into the cannabis market. The company develops cannabis oral dosage formulations thanks to exclusive technology working in the medical cannabis space.
This company officially launched its public stock on the CSE on April 20. “Canntab was able to take this step on only the second anniversary from its date of incorporation, and we intend to continue taking steps like these to enhance shareholder value, increase liquidity and execute on our strategic vision,” Jeff Renwick, CEO and a director of Canntab said.
CannaRoyalty puts together its platform of holdings through royalty agreements, equity interests, convertible debt and licensing agreements across Canada and the US. The Canadian cannabis stock seeks to make investments in cannabis companies for the US market, with a direct focus on California, Nevada, and Florida.
After US Attorney General Jeff Sessions rescinded the Cole Memo, the company issued a statement reassuring shareholders of its position in the American market.
“The evidence from legal states demonstrates that legalizing and regulating cannabis consumption works,” Marc Lusting, CEO of CannaRoyalty said. “It is our belief that this Memorandum has more to do with the DOJ’s desire to ensure its ability to continue to enforce federal law without specific enforcement priorities regarding cannabis, than it does to disrupting ongoing state-legal cannabis activity.”
CROP Infrastructure (CSE:CROP)
CROP works with cannabis companies to offer capital for the acquisition of land real estate, branding and infrastructure for operations in the cannabis investment space.
This year the company has obtained 30 percent interest in facilities located in California and Washington State. “CROP continues to aggressively pursue new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions,” CROP director Alex Horsley said.
Friday Night Inc. (CSE:TGIF)
Friday Night is a cannabis producer based in the state of Nevada, one of the states to most recently legalized the recreational use of cannabis.
The company raised $7.5 million in order to fully capitalize on the high demand of the market in Las Vegas. On June 15, the company began trading on the CSE. Thanks to the boom of the Nevada market, the company is hoping to capitalize on the millions of tourists visiting Las Vegas.
The Canadian cannabis stock announced its intentions to expand its presence into one of the biggest cannabis market available, California.
FinCanna Capital (CSE:CALI)
Next on our stock list for cannabis investment is FinCanna, a royalty company for the licensed medical cannabis industry, with a focus on the California market. The company started trading on December 29, 2017.
Their lead investment is for Cultivation Technologies, which is planning the development of a production facility in Coachella, California.
FSD Pharma (CSE:HUGE)
FSD is a Canadian cannabis company working on the development of an indoor hydroponic cultivation and processing facility, managed by its LP subsidiary FV Pharma. The company started trading on the CSE on May 29.
The facility the company is employing for its growth is a former KRAFT food manufacturing space in Cobourg, Ontario with a 620,000 square feet indoor facility. FSD counts with the support of Auxly Cannabis through a joint-venture agreement. Based on the conditions of the deal Auxly will receive 49.9 percent of the cannabis produced in the facility. “It is anticipated that at full capacity this will result in FV receiving approximately 200,000,000 grams of dried cannabis flower per annum,” FSD wrote in a statement.
Future Farm Technologies (CSE:FFT)
The company works on the development of agriculture technologies for the growth of plants. With the boom of the cannabis industry, Future Farm has expanded their business into marijuana, now representing one of their top 4 business priorities.
Through its subsidiaries, the Canadian cannabis stock has interests in farming projects in California related to the extraction of THC and CBD strains.
Global Cannabis runs a mobile application business related to the cannabis industry. Their products include Citizen Green, Foro, Opinit and Truth.
The Canadian cannabis stock plans to roll out the launch of their cannabis lifestyle apps CannaLife and CannaMed. The company announced it will launch Citizen Green’s CannaMed and CannaLife apps.
Global Hemp Group (CSE:GHG)
Canadian cannabis stock Global Hemp focuses on the acquisition or joint venturing with companies all over the hemp and cannabis sector. The companies in their network include “suppliers of high quality sustainable raw materials and finished products derived from the hemp plant.”
Golden Leaf Holdings (CSE:GLH)
Listed in Canada but located in Oregon, Golden Leaf Holdings is focused on producing high-quality cannabis oils. Currently, the company’s portfolio of brands is to meet the needs of patients, consumer and strategic partners.
The company gained licenses to sell its products in Las Vegas and other areas in the state of Nevada, a market that has expanded in 2017 with incredibly high demand, following the legalization of cannabis.
High Hampton Holdings (CSE:HC)
Next on our stock list for cannabis investment is High Hampton, a cannabis operator focused on the Californian market. Through its subsidiary, CoachellaGro the company is expanding their reach in the state. As the company awaits for a Conditional Use Permit (CUP) for a 10.8-acre CoachellaGro facility located within the Coachella cultivation zone, in January it announced a strategic planning phase.
During the Lift Cannabis Expo in Vancouver this year, CEO David Argudo gave INN an update on the obstacles facing the California cannabis market. On the topic of risk potential for CSE-listed cannabis operators in the US, the company gave an update to shareholders after Canadian Securities Administrators issued a notice asking companies in this space for a risk disclosure update.
“By further clarifying what is expected of an issuer, the CSA offers valuable guidance on disclosure necessities and further reiterates its commitment to follow this disclosure-based approach,” Argudo said in the statement.
HIKU Brands Company (CSE:HIKU)
Hiku is a Canadian cannabis stock whose company is focused on the lifestyle brand aspect of the industry. The company was created by the same team behind the popular Saxx Underwear.
Previously known as DOJA, the company completed a partnership with Tokyo Smoke to morph its public offering into HIKU. DOJA and all it’s LP product are now a subsidiary of the new enterprise.
This Canadian cannabis stock offers financing options to other cannabis cultivators, processors, and dispensaries in the US. The company has deals with licensed producers in four states: Colorado, Massachusetts, New Mexico and Vermont. By guiding these many companies iAnthus has a solid grasp on the cannabis sector in America.
iAnthus currently has almost 20 million invested in five cannabis operations since the start of 2016. “We look forward to making additional investments in greenfield states as well as acquiring assets that have strong track records of revenue growth and cash flow generation,” Julius Kalcevich, CFO of iAnthus, said in a statement.
The Canadian cannabis stock made a push for the Florida market by buying the assets of GrowHealthy Holdings a local Florida company.
InMed Pharmaceuticals (CSE:IN)
InMed is developing therapies for patients through the research of cannabinoids in combination with drug delivery systems. The company has a dermatology product with clinical trials planned all throughout 2020.
The Canadian cannabis stock recently shared some results from its co-sponsored study with the University of British Columbia. “The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens,” InMed said.
Isodiol International (CSE:ISOL)
Through its own online store, Isodiol offers a variety of cannabidiol (CBD) products like oils, sprays, and patches. The company has developed proprietary ISO 9001 and GMP-certified cannabinoid production and purification methods to formulate high-quality CBD products.
Isodiol is one of the first Canadian companies to express an interest in entering the Mexican market, following medical legalization in the country. Isodiol announced in early July that it had received approval from the Brazilian Health Regulatory Agency for its pharmaceutical grade Cannabidiol product, Isoderm.
Lexaria Bioscience (CSE:LXX)
Lexaria is food biosciences company that has the technology for improved delivery of bioactive compounds. In particular, the Canadian cannabis stock offers a variety of hemp oil products to its consumers and also has some novel food offerings like a black tea infused with hemp oil.
Lexaria has filed patents in the US to protect their lipid-based delivery mechanisms. On October 31, the company announced it received a US patent for the use of its “technology as a delivery platform for all cannabinoids including THC; fat-soluble vitamins; non-steroidal anti-inflammatory pain medications; and nicotine.”
Lineage Grow Company (CSE:BUDD)
Lineage is a company focused on holding a lineup of licensed producer assets across the US and Canada. The company currently is seeking assets in Oregon, California, Maryland and Pennsylvania.
In June the company announced an agreement to acquire Agris Farms, a premium quality craft cannabis cultivation company in Northern California.
Koios Beverage (CSE:KBEV)
Koios is a company working on the development of a beverage for brain health purposes. In May the company announced the start of official testing into patients using the Koios products by the NeuraPerformance/Neuroptimize BrainCente. These centers will soon start offering the beverages in its locations.
“Not only will this clinical trial further substantiate our product formulation, but the data collected will pave the way to creating better technologies within our portfolio,” Chris Miller, CEO of Koios said.
Lotus Ventures (CSE:J)
Lotus is a medical marijuana company planning to build a 28,000 square foot facility. Lotus is awaiting a confirmation letter from Health Canada regarding their federal license.
Liberty Health Sciences (CSE:LHS)
Liberty Health is a company focused on cannabis opportunities in the US. They are partnered with Aphria (TSX:APH; OTCQB:APHQF) Currently, Liberty Health is focused on the market available in Florida, including a variety of deals to provide cannabis products to that state.
Liberty Leaf (CSE:LIB)
Liberty Leaf Holdings is focused on the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis investment space. On October 27, the Canadian cannabis stock announced it received an aggregate $763,500 from the exercise of share purchase warrants.
Marapharm Ventures (CSE:MDM)
Next on our stock list for cannabis investment is Marapharm Ventures. The company has two operations in British Columbia. The company’s initial facility–a proposed 22,000 square feet area –will be on an 11-acre site in Kelowna.
Marapharm has also purchased land in Las Vegas for the purpose of building a facility that will host three medical marijuana licenses. What’s more, the company also has the opportunity in Washington to lease a facility to a tier 3 license holder.
Maricann is relatively new to the Canadian cannabis stocks, having joined the CSE under the symbol MARI on April 24th. Maricann expects to be finished with the construction of their Langton facility in 2017, which will up their production square footage from 44,000 to 217,500.
The company gave shareholders an update on its recent financing options, including increasing “the size of the Offering from up to $20,000,000 aggregate principal amount of Convertible Debenture Units to up to $26,000,000 (or up to $31,000,000, factoring in the full exercise of the Agents’ Option (as defined below)).”
Matica Enterprises (CSE:MMJ)
Matica is involved in the acquisition of 70 percent of a late stage ACMPR applicant and builds a 10,000 square foot facility in Quebec.
This facility received its official inspection by the management team of Matica, with CEO Boris Zieger saying their facility is on schedule and should be done by November of 2017.
MedMen Enterprises (CSE:MMEN)
MedMen is a cannabis dispensary operator focused on the US market. The company owns dispensaries in key states like California and Nevada and has been able to hold onto a popularity to its branding and promotion.
MedMen signed onto a partnership with LP Cronos Group for a joint venture and the creation of MedMen Canada, this new entity will oversee the creation of cannabis dispensaries in Canada modeled similarly to the popular MedMen stores in the US.
MPX Bioceutical Corporation (CSE:BCC)
Through its subsidiaries and investments in several states in the US, MPX Bioceutical Corporation is involved in the American cannabis market. Formerly known as Canadian Bioceutical Corporation, the company officially changed its name in November.
The company applied for a Canadian licensed producer (LP) status, but due to a rocky unresponsive process decided to mobilize its investments in the US. On May 22, 2017, the company officially began trading on the OTCQB Market.
MYM Nutraceuticals (CSE:MYM)
Our next Canadian cannabis stocks company is MYM Nutraceuticals, another biopharmaceutical company, and distributor of medical marijuana. It has applied to Health Canada for a production license under MMPR and considers itself well prepared for distribution of medical marijuana, and a growing facility property.
The company has performed a strategy seeking the Australian market, on November 14 the company announced it had completed multiple patent filings with the Office of Drug Control.
NanoSphere is a biotech company working on novel delivery methods. Their relation to the cannabis industry comes in the form of technology. Most recently the Canadian cannabis stock announced a deal with a private-label manufacturer of pharmaceutical goods based in California.
“This new venture not only opens up a huge market, but is a fantastic opportunity to increase our visibility and reputation in the legal cannabis investment space, and represents a significant stepping stone to reaching even more new patients and consumers with our lauded transdermal delivery system,” Robert Sutton, Chairman and CEO at NanoSphere said.
Nutritional High (CSE:EAT)
Nutritional High is a Canadian cannabis stock focused on cannabis-infused edible products and oil extracts for both the medical and recreational market. On October 8, the company announced it was entering into a novel cannabis market: beverages. The company “entered into an agreement with Xanthic Biopharma to manufacture and distribute their innovative cannabis-infused powdered drinks and other products in Colorado.
Phivida Holdings (CSE:VIDA)
Next on our stock list for cannabis investment is Phivida. The company works on CBD infused foods and beverages and clinical CBD products. Most recently the company announced an agreement with Namaste Technologies (CSE:N; OTCMKTS:NXTTF) to distribute their products in Germany and Australia.
“This Agreement represents a pilot project between both companies whereby Namaste will distribute Phivida’s proprietary CBD beverages and infused products within the designated territories,” the companies announced on their joint statement.
PUF Ventures (CSE:PUF)
PUF Ventures has a diversified portfolio of assets in the Canadian marijuana sector. It owns a passive, non-controlling interest in AAA Heidelberg, which is focused on using all-natural nutrients to grow healthy, pest-free plants.
AAA Heidelberg has had an MMPR application pending with Health Canada since 2013. Other ventures the company has invested in include 1313 Cigs, VapeTronix, and Weed Beacon. In late January, the Canadian cannabis stock announced it had recommenced its development of the WeedBacon platform.
Quadron Capital Corporation (CSE:QCC)
Quadron works to help licensed producers in Canada with “complex needs and requirements” through equipment, products, and services. The company also offers dispensing devices and consumption products. The company has two subsidiaries in Soma Labs Scientific, Greenmantle, and Cybernetic Control Systems.
During its most recent financial disclosure, the Canadian cannabis stock announced an increase in revenue to $516,211 during their first quarter.
RISE Life Science (CSE:RLSC)
RISE Life Science is a company developing cannabis consumer products for both medical and adult-use markets. The company plans to establish a potential capacity in 2019 to market all of its CBD products throughout the US, Canadian and European markets.
In June the company provided shareholders with a corporate update to project the entry of sexual health cannabis products this year. “RISE products are expected to be available in California retail locations by the end of July and will be offered through dispensaries initially, followed by health food retailers and natural wellness boutiques,” the company indicated.
Another fairly new member of the Canadian cannabis stocks is TerrAscend, who went public in May 2017 when it entered the Canadian Securities Exchange. The company’s subsidiary, Solace Health, is in the process of applying for an official licensing designation from Health Canada. Solace is host to a 67,000 square feet production facility
The company’s other subsidiary Terra Health Network is a research-based cannabinoid medical group, which wants to improve the medical cannabis solutions available for patients with chronic pain and debilitating illnesses.
THC Biomed (CSE:THC)
Next on our stock list for cannabis investment is THC Biomed, who has been granted permission to conduct research and development for scientific purposes with medicinal marijuana. The company provides scientific and biotechnical services to current and potential licensed producers. In May 2016, Health Canada granted TCH BioMed a license to produce fresh marijuana, cannabis oil, and cannabis resin.
Tinley Beverage (CSE:TNY)
Tinley Beverage is the producer of Hemplify, a drinkable vitality supplement containing hemp extract made from the stalk of industrial hemp. The vegan, sugar-free drink is a source of electrolytes, vitamins and Omega 3 fatty acids. The company reported receiving its first orders for Hemplify products on March 10, 2016. In August 2016 the company launched its web store at www.drinkhemplify.com and listed its flagship “Hemplify” product for sale on Amazon.
True Leaf Medicine (CSE:MJ)
Canada-based True Leaf is slightly different than the afore-mentioned Canadian cannabis stocks; the company is focused on the production of hemp-based functional dog chews. In August 2016, the company secured the first order for its True Hemp pet products with Pets Corner, the second largest pet store chain in the United Kingdom. The store will sell the product in all of its 174 stores. The sale also means that True Hemp is now generating revenue on two continents – North America and Europe. “We’re on our way to becoming a truly global brand,” said CEO Darcy Bomford.
Valens GroWorks (CSE:VGW)
Located in British Columbia’s Okanagan Valley, our next Canadian cannabis stocks is Valens GroWorks, a “rapidly emerging” with a focus on cannabis cultivation and research. In November the company announced it had increased a private placement offer in order to advance the operational capability of its Kelowna Facility.
Veritas Pharma (CSE:VRT)
Veritas is working on fully understanding the medical capabilities of marijuana, the company’s mission is to find the most effective strains that target a specific disease condition. Veritas is using a specifically designed approach to their research where they chemically and pharmacologically profile the plant. As a last check, they completed a clinical study of each cultivar.
Vinergy Resources (CSE:VIN)
Vinergy is an oil and gas company, that acquired MJ BioPharma, a cannabis technology company focused on manufacturing breath strips, time release capsules, extract oils, food products, and infused juices, teas, coffee and extract drinks and pharmaceutical grade delivery systems.
The pair announced in February the had developed an oral cannabinoid complex delivery strips and controlled time release capsule technology. “We think time release capsules are extremely important as they help bridge the gap in terms of familiarity with many patients who want to switch from synthetic drugs to a natural product as a way to reduce side effects and drug,” said Mr. Kent Deuters, CEO of MJ Biopharma.
Vodis Pharmaceuticals (CSE:VP)
Next on our stock list for cannabis investment is Vodis. The firm has medical and recreational marijuana business operations in both Canada and the United States. With facilities in BC and Washington State, Vodis is actively seeking expansion opportunities in other countries and US states.
In March, the company announced it, together with Our Church International, signed a 15-year licensing and marketing agreement. Later that month, Vodis announced construction had begun on its Bellingham cannabis facility. Following that, the Canadian cannabis stock announced its USA-branded product had begun selling in Washington State. On June 20, Vodis announced a $5 million private placement financing.
Wildflower Brands (CSE:SUN)
Working exclusively in Washington State, Wildflower Marijuana lists in Canada, with a focus on developing and designing products in the cannabis sector.
On June 27, Wildflower announced that its products would soon be coming to Amazon.com–which shouldn’t come as a surprise. Earlier in June, the company announced a brand expansion into the American market.
Xanthic Biopharma (CSE:XTHC)
Last but not least on our stock list for cannabis investment is Xanthic. It is a company working with strategic partners to deliver a higher quality of cannabinoid solubility, improved bioavailability, accurate micro-dosing and greater consistency versus competitive infused products, thanks to a patent-pending process.
In May a strategic partner of the company, Avitas CBD Water, rebranded into Xanthic Beverages. “With a business model focused on licensing our water-soluble technology and brand name to qualified producers, being able to demonstrate initial success on the West Coast of the US with Xanthic CBD Water will be extremely valuable,” Tim Moore, CEO of Xanthic said.
Maple Leaf Green World (NEO: MGW)
Maple Leaf is a company with interests in both the Canadian and US cannabis markets. The company’s facility in Telkwa, B.C. is in the process of applying for federal license to grow medical marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR). In the US the company holds a medical cultivation license in Nevada and is seeking a recreational one as well.
In 2018 Maple Leaf elected to drop the TSXV Exchange, in which it previously traded for the fairly new Aequitas NEO Exchange, a first of its kind move in the cannabis space.
Do you want to venture into the cannabis investment space? Why or why not?
Did we miss a company that you think should be included on the Canadian cannabis stocks list? Let us know in the comments!
This article has been updated since its original publication in 2016, with the most recent update done by Bryan Mc Govern.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Jocelyn Aspa and Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Xanthic Biopharma, Koios Beverage, FluroTech, Canntab, Lineage Grow, RISE Life Science, CROP Infrastructure, Maricann, Khiron Life Sciences, The Green Organic Dutchman, ABcann Global, Harvest One Cannabis, INDIVA, Invictus MD, Kalytera Therapeutics, Maple Leaf Green World, Naturally Splendid, The Supreme Cannabis Company, WeedMD, Beleave, Friday Night Inc., FinCanna Capital, Emblem, Global Cannabis Application, High Hampton Holdings, HIKU Brands Company, Isodiol International, Lexaria Bioscience, MYM Nutraceuticals, PUF Ventures, Valens GroWorks and Vodis Pharmaceuticals are clients of the Investing News Network. This article is not paid-for content.